MEDFAR Solutions

Cloud-based EMR for doctors and clinics

MEDFAR Solutions

Cloud-based EMR for doctors and clinics

Overview

Medfar Solutions provides cloud-based electronic medical record (EMR) software for doctors and private clinics. Its flagship product, MYLE, streamlines clinical workflows with a user-friendly interface, customizable medical summaries, and quick access to patient information. It supports solo practitioners and group practices, and includes advanced analytics to generate reports, charts, and statistics for decision-making and research. The business relies on subscription fees, serving over 3,000 healthcare professionals. Compared with competitors, MYLE emphasizes tailored workflows for clinicians, flexible deployment for individual and multi-provider practices, and integrated analytics to improve patient care and operational efficiency. The company's goal is to help medical teams deliver better patient care and run their operations more efficiently through cloud EMR technology.

Work here?Claim your company

About MEDFAR Solutions

Simplify's Rating

Why MEDFAR Solutions is rated

B-

Rated B on Competitive Edge

Rated B on Growth Potential

Rated C on Differentiation

Industries

Data & AnalyticsEnterprise SoftwareHealthcare

Company Size

201-500

Company Stage

Series C

Total Funding

$40.3M

Headquarters

Montreal, Canada

Founded

2010

Get referred to MEDFAR Solutions

See people who can refer or advise you

Simplify's take

What believers are saying

AlloMia handles about 50% of calls end-to-end in pilot clinics by October 2026.
MEDFAR posted active hiring in October 2026 for revenue, product, and security roles.
The 2024 COMTRON acquisition gives MYLE a U.S. foothold through Medgen, LABGEN, and RCM.

What critics are saying

TELUS Health and QHR dominate Canadian EMRs, squeezing MEDFAR outside Quebec.
AlloMia and CareWay integration failures would disrupt clinics and trigger churn within 2027.
MEDFAR's small Ontario footprint, 191 physicians, limits US expansion and makes MYLE regional.

What makes MEDFAR Solutions unique

MYLE embeds AI scribe, form-filling, indexing, and call agents inside workflows.
MEDFAR acquired CareWay in 2025 and AlloMia in 2026, deepening in-house AI.
OntarioMD certified MYLE and Quebec adoption anchors local distribution and switching costs.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$40.3M

Below

Industry Average

Funded Over

2 Rounds

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.

Series C Funding Comparison

Below Average

Industry standards

Ind Avg. $50M

$40M

$50M

$62M

$100M

Benefits

Hybrid Work Options
Remote Work Options
Flexible Work Hours
Paid Vacation
Paid Holidays
401(k) Retirement Plan
401(k) Company Match
Wellness Program
Mental Health Support
Conference Attendance Budget
Professional Development Budget
Stock Options

Growth & Insights and Company News

6 month growth

1 year growth

2 year growth

Newswire

Oct 14th, 2026

MEDFAR acquires AlloMia to add AI voice agents to its MYLE medical records platform

MEDFAR, the Canadian company behind the electronic medical record (EMR) system MYLE, has acquired AlloMia, which develops AI voice agents that answer patient calls for clinics. It is MEDFAR's second AI acquisition in under two years. No price was disclosed. AlloMia's agent answers calls instantly, books appointments into the clinic's schedule, and directs callers to the right resource. It has been piloted with a group of MYLE clinics since March 2026. In the newest clinics, about 50% of calls are handled start to finish without a transfer to reception. The agent becomes MYLE's fourth AI feature, joining AI Scribe, AI Form-Filling, and AI Indexing. It is available to all MYLE clinics and works with the Plexia and Medgen EMRs. The AlloMia team has joined MEDFAR.

PE Hub

Mar 5th, 2025

Walter Capital Partners-backed Medfar acquires CareWay

In 2021, Walter Capital led a C$25m minority investment in Medfar

Newswire

Mar 5th, 2025

MEDFAR Acquires CareWay: Pioneering the Most Intelligent EMR in Canada Français

MONTRÉAL, March 5, 2025 /CNW/ - MEDFAR, the developer of the leading electronic medical record (EMR) platform MYLE, is pleased to announce the acquisition of CareWay, a Canadian pioneer in artificial intelligence (AI) for healthcare.

CanHealth

Aug 14th, 2024

MEDFAR Expands in US EMR Market

MEDFAR, a leading Canadian EMR provider, has acquired New York-based COMTRON, including Medgen EHR, LABGEN LIS, and RCM software, expanding its footprint in the U.S. primary care market. This integration enhances MEDFAR's MYLE Integrated Care Platform, streamlining primary care workflows and benefiting patients, labs, and providers. The acquisition aligns with MEDFAR's goal to support 5 million care providers in delivering high-quality care to 500 million patients globally.

PR Newswire

Aug 8th, 2024

Medfar, Fastest-Growing Emr/Ehr Provider, Announces Successful Entry Into The U.S. Primary Care Market With Comtron Integration

MEDFAR Unveils New Brand Identity Reflecting Its Growth and Ambitious Healthcare GoalsMONTREAL, Aug. 8, 2024 /PRNewswire/ - MEDFAR, developer of the Integrated Care Platform MYLE and leading Canadian EMR provider, has successfully completed the integration of New York-based COMTRON, establishing a strategic foothold in the U.S. primary care market. With the acquisition of Medgen electronic health records (EHR), LABGEN LIS for medical laboratories, and revenue cycle management (RCM) software & services, MEDFAR now offers a comprehensive suite of tools for primary healthcare professionals across the United States.Since pioneering the first web-based EMR in Quebec, MEDFAR's innovative approach has fueled steady and exponential growth. Its core product, the MYLE Integrated Care Platform, has become the #1 solution used by primary care teams, and is the fastest growing EMR in Canada."This latest integration fast tracks MEDFAR's mission of driving excellence and efficiency in healthcare globally," said Elias Farah, CEO and co-founder of MEDFAR. "Lab Information System (LIS) and advanced RCM software and service capabilities add a crucial dimension to our MYLE Integrated Care Platform

Recently Posted Jobs